首页> 外文OA文献 >Molecular and functional interactions between adenosine and dopamine receptors. New therapeutic targets for the treatment of Parkinson's disease.
【2h】

Molecular and functional interactions between adenosine and dopamine receptors. New therapeutic targets for the treatment of Parkinson's disease.

机译:腺苷和多巴胺受体之间的分子和功能相互作用。用于治疗帕金森氏病的新治疗靶标。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Adenosine and dopamine receptors are members of the GPCRs family for which a significant segregation between their A2A and D2 subtypes has been demonstrated in the GABAergic striopallidal neurons of the basal ganglia. In addition, several reports suggest an antagonistic interaction between these subtypes at different levels. For this reason the first study has been focused in the characterization of the molecular and functional interaction between A2AR and D2R. Colocalization of these receptors and clustering upon agonist stimulation has been observed by double immunocytochemistry in neuroblastoma SH-SY5Y cells as well as in primary cultures of striatal neurons. In addition, in the neuroblastoma cell line, it has been demonstrated that the internalization of both receptors takes place following their clusterization. Despite the A2AR-D2R heteromerization has been determined by coimmunoprecipitation, we have also studied if this interaction occurs in living cells by using FRET (Fluorescence Resonance Energy Transfer) and BRET (Bioluminescence Resonance Energy Transfer) approaches. Finally, using both, experimental and theoretical modeling data, it is suggested that the helix 5 and 6 and the 3rd intracellular loop of the D2R and the C-terminal tail of the A2AR are important domains for the formation of the A2AR-D2R heteromers. The homodimerization of the adenosine A2AR has also been studied by FRET and BRET. Furthermore, TR-FRET (Time-Resolved FRET) and biotinylation experiments have suggested that the homodimer, not the monomer, is the functional form of the receptor that reaches the cell surface. The last part of this study has been focused in the identification of the adenosine receptors that mediate the regulation of neuronal differentiation and the molecular mechanisms involved in this effect. Agonist-induced stimulation of A1Rs and A2ARs induces neurite outgrowth processes in the human neuroblastoma SH-SY5Y cell line and also in striatal neuronal precursor cells in primary cultures. The triggering of the expression of TrkB receptor and the arrest of cells in the G1 phase by the activation of adenosine receptors suggest that adenosine may participate in early steps of neuronal differentiation. Furthermore, the signaling transduction pathway involved in these effects have been shown to require both, the MAPK and the PKC activation but in an independent manner. The results presented in this work, therefore, suggest that adenosine not only acts as a key neuromodulator in information handling but also exerts trophic effects that can enhance neuronal differentiation and neuronal repair.
机译:腺苷和多巴胺受体是GPCR家族的成员,其A2A和D2亚型之间的显着分离已在基底神经节的GABA能性纹状睑神经元中得到证实。另外,一些报道表明这些亚型之间在不同水平上有拮抗作用。因此,第一项研究集中在表征A2AR和D2R之间的分子和功能相互作用上。通过双重免疫细胞化学已经在神经母细胞瘤SH-SY5Y细胞以及纹状体神经元的原代培养物中观察到了这些受体的共定位和在激动剂刺激下的聚集。另外,已经证明在神经母细胞瘤细胞系中,两种受体的内化都在它们的聚集之后发生。尽管已经通过共免疫沉淀法确定了A2AR-D2R异源化,但我们还通过使用FRET(荧光共振能量转移)和BRET(生物发光共振能量转移)方法研究了这种相互作用是否在活细胞中发生。最后,利用实验和理论建模数据,建议D2R的螺旋5和6以及第3个胞内环和A2AR的C末端尾巴是形成A2AR-D2R异聚体的重要域。 FRET和BRET也研究了腺苷A2AR的同二聚化。此外,TR-FRET(时间分辨FRET)和生物素化实验表明,同源二聚体而不是单体是到达细胞表面的受体的功能形式。这项研究的最后一部分集中于鉴定介导神经元分化调节的腺苷受体和涉及该效应的分子机制。激动剂诱导的A1R和A2AR的刺激在人神经母细胞瘤SH-SY5Y细胞系以及原代培养的纹状体神经元前体细胞中诱导神经突生长过程。 TrkB受体的表达的触发和腺苷受体的激活使细胞停滞在G1期表明,腺苷可能参与神经元分化的早期步骤。此外,已经显示出涉及这些作用的信号转导途径既需要MAPK激活又需要PKC激活,但是需要独立的方式。因此,这项工作中提出的结果表明,腺苷不仅充当信息处理中的关键神经调节剂,而且发挥营养作用,可增强神经元分化和神经元修复。

著录项

  • 作者

    Canals Buj Meritxell;

  • 作者单位
  • 年度 2004
  • 总页数
  • 原文格式 PDF
  • 正文语种 {"code":"es","name":"Spanish","id":10}
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号